Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30863148)

  • 1. Claudin gene expression profiles and clinical value in colorectal tumors classified according to their molecular subtype.
    Cherradi S; Martineau P; Gongora C; Del Rio M
    Cancer Manag Res; 2019; 11():1337-1348. PubMed ID: 30863148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer.
    Yang L; Zhang W; Li M; Dam J; Huang K; Wang Y; Qiu Z; Sun T; Chen P; Zhang Z; Zhang W
    Front Genet; 2022; 13():783016. PubMed ID: 35281827
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of claudin-2, -6, -11 and -14 as prognostic markers in human breast carcinoma.
    Jia H; Chai X; Li S; Wu D; Fan Z
    Int J Clin Exp Pathol; 2019; 12(6):2195-2204. PubMed ID: 31934042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Consensus Molecular Subtypes and Molecular Markers With Clinical Outcomes in Patients With Metastatic Colorectal Cancer: Biomarker Analyses From LUME-Colon 1.
    Lenz HJ; Argiles G; Yoshino T; Tejpar S; Ciardiello F; Braunger J; Salnikov AV; Gabrielyan O; Schmid R; Höfler J; Kitzing T; Van Cutsem E
    Clin Colorectal Cancer; 2021 Mar; 20(1):84-95.e8. PubMed ID: 33041226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of claudin‑1, ‑3, ‑7 and ‑8 as prognostic markers in human laryngeal carcinoma.
    Zhou S; Piao X; Wang C; Wang R; Song Z
    Mol Med Rep; 2019 Jul; 20(1):393-400. PubMed ID: 31115553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody targeting of claudin-1 as a potential colorectal cancer therapy.
    Cherradi S; Ayrolles-Torro A; Vezzo-Vié N; Gueguinou N; Denis V; Combes E; Boissière F; Busson M; Canterel-Thouennon L; Mollevi C; Pugnière M; Bibeau F; Ychou M; Martineau P; Gongora C; Del Rio M
    J Exp Clin Cancer Res; 2017 Jun; 36(1):89. PubMed ID: 28659146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
    Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
    Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic subtypes predict outcomes in colorectal cancer.
    Kasurinen J; Beilmann-Lehtonen I; Kaprio T; Hagström J; Haglund C; Böckelman C
    Acta Oncol; 2023 Mar; 62(3):245-252. PubMed ID: 36867078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Ten Hoorn S; de Back TR; Sommeijer DW; Vermeulen L
    J Natl Cancer Inst; 2022 Apr; 114(4):503-516. PubMed ID: 34077519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of claudins and prognostic factors in some gastrointestinal diseases].
    Gyorffy H
    Magy Onkol; 2009 Dec; 53(4):377-83. PubMed ID: 20071310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial.
    Mooi JK; Wirapati P; Asher R; Lee CK; Savas P; Price TJ; Townsend A; Hardingham J; Buchanan D; Williams D; Tejpar S; Mariadason JM; Tebbutt NC
    Ann Oncol; 2018 Nov; 29(11):2240-2246. PubMed ID: 30247524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and clinicopathological differences between depressed and protruded T2 colorectal cancer.
    Mochizuki K; Kudo SE; Kato K; Kudo K; Ogawa Y; Kouyama Y; Takashina Y; Ichimasa K; Tobo T; Toshima T; Hisamatsu Y; Yonemura Y; Masuda T; Miyachi H; Ishida F; Nemoto T; Mimori K
    PLoS One; 2022; 17(10):e0273566. PubMed ID: 36264865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the distribution pattern of Claudin tight junction proteins during the progression of mouse skin tumorigenesis.
    Arabzadeh A; Troy TC; Turksen K
    BMC Cancer; 2007 Oct; 7():196. PubMed ID: 17945025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cofilin-1, LIMK1 and SSH1 are differentially expressed in locally advanced colorectal cancer and according to consensus molecular subtypes.
    Sousa-Squiavinato ACM; Vasconcelos RI; Gehren AS; Fernandes PV; de Oliveira IM; Boroni M; Morgado-Díaz JA
    Cancer Cell Int; 2021 Jan; 21(1):69. PubMed ID: 33482809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of key claudin genes associated with survival prognosis and diagnosis in colon cancer through integrated bioinformatic analysis.
    Alghamdi RA; Al-Zahrani MH
    Front Genet; 2023; 14():1221815. PubMed ID: 37799140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stratification of Colorectal Patients Based on Survival Analysis Shows the Value of Consensus Molecular Subtypes and Reveals the CBLL1 Gene as a Biomarker of CMS2 Tumours.
    Alfonsín G; Berral-González A; Rodríguez-Alonso A; Quiroga M; De Las Rivas J; Figueroa A
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer.
    Smeby J; Sveen A; Merok MA; Danielsen SA; Eilertsen IA; Guren MG; Dienstmann R; Nesbakken A; Lothe RA
    Ann Oncol; 2018 May; 29(5):1227-1234. PubMed ID: 29518181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer.
    Ma F; Ding X; Fan Y; Ying J; Zheng S; Lu N; Xu B
    PLoS One; 2014; 9(11):e112765. PubMed ID: 25393310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Expression of the Claudin Family of Proteins in Colorectal Cancer.
    Cox KE; Liu S; Hoffman RM; Batra SK; Dhawan P; Bouvet M
    Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of colorectal cancer in accordance with consensus molecular subtype classification.
    Sawayama H; Miyamoto Y; Ogawa K; Yoshida N; Baba H
    Ann Gastroenterol Surg; 2020 Sep; 4(5):528-539. PubMed ID: 33005848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.